Serum biochemical markers of brain injury

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 2, 2009, Pages 227-234

  Korfias, S ^a,b   Papadimitriou, A ^a   Stranjalis, G ^a   Bakoula, C ^a   Antsaklis, A ^a   Sakas, D E ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Alexandra Hospital ^*  (Greece)

Author keywords

Brain biochemical markers; Brain injury; Brain tumours; Ischaemia; Neurotrauma; Stroke; Subarachnoid haemorrhage; Tbi

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE; CREATINE KINASE BB; FATTY ACID BINDING PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN 70; INTERCELLULAR ADHESION MOLECULE 1; LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; OXYGEN; PROTEIN S100B; RANTES; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; NERVE PROTEIN;

BLOOD ANALYSIS; BRAIN BLOOD FLOW; BRAIN CELL; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; BRAIN INJURY; CELL DAMAGE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; GLASGOW COMA SCALE; HEMODYNAMIC MONITORING; HUMAN; INTRACRANIAL PRESSURE; MEDICAL ASSESSMENT; MEDICAL RESEARCH; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PATIENT CARE; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; ANIMAL; BLOOD; INFLAMMATION; METABOLISM; REPRODUCIBILITY;

ANIMALS; BIOLOGICAL MARKERS; BRAIN INJURIES; HUMANS; INFLAMMATION; NERVE TISSUE PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 65449147492     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709787315994     Document Type: Review

References (107)

1. Bakay, R.; Ward, A. Enzymatic changes in serum and cerebrospinal fluid in neurological injury. J. Neurosurg., 1983, 58, 27-37.
2. Berg, J.; Tymoczko, J.; Stryer, L. Biochemistry, W.H. Freeman & Company: New York, 2006.
3. Martin, D.; Mayes, P.; Rodwell, V. Harpers's Review of Biochemistry. Lange Medical Publications: Los Altos, California, 1985.
4. Ingebrigten, T.; Rommer, B. Biochemical serum markers of traumatic brain injury. J. Trauma, 2002, 52, 798-808.
5. Johnsson, P. Markers of cerebral ischemia after cardiac surgery. J. Cardiothorac. Vasc. Anesth., 1996, 10, 120-6.
6. Kaste, M.; Hernesniemi, J.; Somer, H.; Hillborn, M.; Konttinen A. Creatine kinase isoenzymes in acute brain injury. J. Neurosurg., 1981, 55, 511-5.
7. Cooper, P.R.; Chalif, D.J., Ramsey, J.F.; Moore, R.J. Radioimmunoassay of the brain type isoenzyme of creatine phosphokinase (CK-BB): a new diagnostic tool in the evaluation of patients with head injury. Neurosurgery, 1983, 12, 536-41.
8. Skogseid, I.M.; Nordby, H.K.; Urdal, P.; Paus, E.; Lilleaas, F. Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir. (Wien), 1992, 115, 106-11.
9. Levitt, M.A.; Cook, L.A.; Simon, B.C.; Williams, V. Biochemical markers of cerebral injury in patients with minor head trauma and ethanol intoxication. Acad. Emerg. Med., 1995, 2, 675-80.
10. Eng, L.F.; Vanderhaeghen, J.J.; Bignami, A.; Gerstl, B. An acidic protein isolated from fibrous astrocytes. Brain Res., 1971, 28, 351-4.
11. Missler, U.; Wiesmann, M.; Wittmann, G.; Magerkurth, O.; Hagenstrom, H. Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary results. Clin. Chem., 1999, 45, 138-41.
12. Pelinka, L.E.; Kroepfl, A.; Schmidhammer, R.; Krenn, M.; Buchinger, W.; Redl, H.; Raabe, A. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J. Trauma, 2004, 57, 1006-12.
13. Nylén, K.; Ost, M.; Csajbok, L.Z.; Nilsson, I.; Blennow, K.; Nellgård, B.; Rosengren, L. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J. Neurol. Sci., 2006, 240, 85-91.
14. Herrmann, M.; Vos, P.; Wunderlich, M.T.; De Bruijn, C.H.; Lamers, K.J. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke, 2000, 31, 2670-7.
15. Nylen, K.; Csajbok, L.Z.; Ost, M.; Rashid, A.; Blennow, K.; Nellgard, B.; Rosengren, L. Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage. Stroke, 2007, 38, 1489-94.
16. Thomas, D.G.; Palfreyman J.W.; Ratcliffe, J.G. Serum-myelinbasic-protein assay in diagnosis and prognosis of patients with head injury. Lancet, 1978, 21, 113-5.
17. Thomas, D.G.; Rabow, L.; Teasdale, G. Serum myelin basic protein, clinical responsiveness, and outcome of severe head injury. Acta Neurochir. Suppl. (Wien), 1979, 28, 93-5.
18. Yamazaki, Y.; Yada, K.; Morii, S.; Kitahara, T.; Ohwada, T. Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg. Neurol., 1995, 43, 267-70.
19. Marangos, P.J.; Schmechel, D.E. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Ann. Rev. Neurosci., 1987, 10, 269-95.
20. Ergun, R.; Bostanci, U.; Akdemir, G.; Beşkonakli, E.; Kaptanoǧlu, E.; Gürsoy, F.; Taşkin, Y. Prognostic value of serum neuron-specific enolase levels after head injury. Neurol. Res., 1998, 20, 418-20.
21. Ross, S.A.; Cunningham, R.T.; Johnston, C.F.; Rowlands, B.J. Neuron-specific enolase as an aid to outcome prediction in head injury. Br. J. Neurosurg., 1996, 10, 471-6.
22. McKeating, E.G.; Andrews, P.J.; Mascia, L. Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochir. Suppl. (Wien), 1998, 71, 117-9.
23. Woertgen, C.; Rothoerl, R.D.; Holzschuh, M.; Metz, C.; Brawanski, A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir. (Wien), 1997, 139, 1161-4.
24. Missler, U.; Wiesmann, M.; Friedrich, C.; Kaps, M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke, 1997, 28, 1956-60.
25. Donato, R. Functional roles of S-100 proteins, calcium-binding proteins of the EF-hand type. Biochim. Biophys. Acta, 1999, 1450, 191-231.
26. Moore, B.W. A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun., 1965, 19, 739-44.
27. Isobe, T.; Okuyama, T. The amino acid sequence of S-100 protein (PAP I-b protein) and its relation to the calcium-binding proteins. Eur. J. Biochem., 1978, 89, 379-88.
28. Isobe T, Okuyama T. The amino acid sequence of the alpha subunit in bovine brain S-100a protein. Eur. J. Biochem., 1981, 116, 79-86.
29. Beaudeux, J.; Dequen, L.; Foglietti, M. Pathophysiologic aspects of S-100 beta protein: a new biological marker of brain pathology. Ann. Biol. Clin., 1999, 57, 261-72.
30. Schafer, B.W.; Wicki, R.; Engelkamp, D.; Mattei, M-G.; Heizmann, C. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: Rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics, 1995, 25, 638-43.
31. Schafer, B.; Heizmann, C.W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem. Sci., 1996, 21, 134-40.
32. Heizmann, C.W.; Fritz, G.; Schafer, B.W. S100 proteins: structure, functions and pathology. Front. Biosci., 2002, 7, 1356-68.
33. Wicki, R.; Marenholz, I.; Mischke, D.; Schafer, B.W.; Heizmann, C.W. Characterization of the human S100A12 (calgranulin C, p6, CAAF1, CGRP) gene, a new member of the S100 gene cluster on chromosome 1q21. Cell Calcium, 1996, 20, 459-64.
34. Ridinger, K.; Schafer, B.W.; Durussel, I.; Cox, J.A.; Heizmann, C.W. S100A13. Biochemical characterization and subcellular localization in different cell lines. J. Biol. Chem., 2000, 24, 8686-94.
35. Pietas, A.; Schluns, K.; Marenholz, I.; Schafer, B.W.; Heizmann, C.W.; Petersen, I. Molecular cloning and characterization of the human S100A14 gene encoding a novel member of the S100 family. Genomics, 2002, 79, 513-22.
36. Donato, R. S-100 proteins. Cell Calcium, 1986, 7, 123-45.
37. Donato, R. Perspectives in S-100 protein biology. Review article. Cell Calcium, 1991, 12, 713-26.
38. Cocchia, D.; Michetti, F.; Donato, R. Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin. Nature, 1981, 294, 85-7.
39. Townend, W.; Dibble, C.; Abrid, K.; Vail, A.; Sherwood, R.; Lecky, F. J. Rapid elimination of protein S-100B from serum after minor head trauma. Neurotrauma, 2006, 23, 149-55.
40. Jackson, R.G.; Samra, G.S.; Radcliffe, J.; Clark, G.H.; Price, C.P. The early fall in levels of S-100 beta in traumatic brain injury. Clin. Chem. Lab. Med., 2000, 38, 1165-7.
41. Wiesmann, M.; Missler, U.; Gottmann, D.; Gehring, S. Plasma S-100b protein concentration in healthy adults is age- and sex-independent. Clin. Chem., 1998, 44, 1056-8.
42. Biberthaler, P.; Mussack, T.; Wiedemann, E.; Kanz, K.G.; Gilg, T.; Gippner-Steppert, C.; Jochum, M. Influence of alcohol exposure on S-100B serum levels. Acta Neurochir. Suppl., 2000, 76, 177-9.
43. Biberthaler, P.; Mussack, T.; Wiedemann, E.; Gilg, T.; Soyka, M.; Koller, G.; Pfeifer, K.J.; Linsenmaier, U.; Mutschler, W.; Gippner-Steppert, C.; Jochum, M. Elevated serum levels of S-100 reflect the extent of brain injury in alcohol intoxicated patients after mild head trauma. Shock, 2001, 16, 97-101.
44. Mussack, T.; Ladurner, R. Role of S-100B for evaluation of traumatic brain injury in patients with alcohol intoxication. Recenti. Prog. Med., 2005, 96, 77-80.
45. Raabe, A.; Menon, D.; Gupta, S.; Czosnyka, M.; Pickard, J.D. Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study. J. Neurol. Neurosurg. Psychiatry, 1998, 65, 930-2.
46. Raabe, A.; Kopetsch, O.; Gross, U.; Zimmermann, M.; Gebhart, P. Measurements of serum S-100B protein: effects of storage time and temperature on pre-analytical stability. Clin. Chem. Lab. Med., 2003, 41, 700-3.
47. Smit, L.H.; Korse, C.M.; Bonfrer, J.M. Comparison of four different assays for determination of serum S-100B. Int. J. Biol. Markers, 2005, 20, 34-42.
48. Ingebrigtsen, T.; Romner, B.; Kongstad, P.; Langbakk, B. Increased serum concentrations of protein S-100 after minor head injury: A biochemical serum marker with prognostic value? J. Neurol. Neurosurg. Psychiatry, 1995, 59, 103-4.
49. Donato, R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol., 2001, 33, 637-68.
50. Korfias, S.; Stranjalis, G.; Papadimitriou, A.; Psachoulia, C.; Daskalakis, G.; Antsaklis, A.; Sakas, D.E. Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr. Med. Chem., 2006, 13, 3719-31.
51. Raabe, A.; Grolms, C.; Sorge, O.; Zimmermann, M.; Seifert, V. Serum S-100B protein in severe head injury. Neurosurgery, 1999, 45, 477-83.
52. Raabe, A.; Grolms, C.; Seifert, V. Serum markers of brain damage and outcome prediction in patients after severe head injury. Br. J. Neurosurg., 1999, 13, 56-9.
53. Raabe, A.; Seifert, V. Fatal secondary increase in serum S-100B protein after severe head injury. J. Neurosurg., 1999, 91, 875-7.
54. Woertgen, C.; Rothoerl, R.D.; Metz, C.; Brawanski, A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J. Trauma, 1999, 47, 1126-30.
55. Rothoerl, R.D.; Woertgen, C.; Brawanski, A. S-100 serum levels and outcome after severe head injury. Acta Neurochir. Suppl., 2000, 76, 97-100.
56. Woertgen, C.; Rothoerl, R.D.; Holzschuh, M.; Metz, C.; Brawanski, A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir. (Wien), 1997, 139, 1161-4.
57. Rothoerl, R.D.; Woertgen, C.; Holzschuh, M.; Metz, C.; Brawanski, A. Rapid evaluation of S-100 serum levels. Case report and comparison to previous results. Brain Inj., 1999, 13, 387-91.
58. Herrmann, M.; Jost, S.; Kutz, S.; Ebert, A.D.; Kratz, T.; Wunderlich, M.T.; Synowitz, H. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J. Neurotrauma, 2000, 17, 113-22.
59. Pleines, U.E.; Morganti-Kossmann, M.C.; Rancan, M.; Joller, H.; Trentz, O.; Kossmann, T. S-100beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J. Neurotrauma, 2001, 18, 491-8.
60. Dimopoulou, I.; Tsagarakis, S.; Korfias, S.; Zervakis, D.; Douka, E.; Thalassinos, N.; Sakas, D.E.; Roussos, C. Relationship of thyroid function to post-traumatic S-100b serum levels in survivors of severe head injury: preliminary results. Intens. Care Med., 2004, 30, 298-301.
61. Romner, B.; Ingebrigtsen, T.; Kongstad, P.; Borgesen, S.E. Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J. Neurotrauma, 2000, 17, 641-7.
62. Petzold, A.; Green, A.; Keir, G.; Fairley, S.; Kitchen, N.; Smith, M.; Thompson, E.J. Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: A pilot study. Crit. Care Med., 2002, 30, 2705-10.
63. Korfias, S.; Stranjalis, G.; Boviatsis, E.; Psachoulia, C.; Jullien, G.; Gregson, B.; Mendelow, A.D.; Sakas, D.E. Serum S-100B protein monitoring in patients with severe traumatic brain injury. Intens. Care Med., 2007, 33, 255-60.
64. Dimopoulou, I.; Korfias, S.; Dafni, U.; Anthi, A.; Psachoulia, C.; Jullien, G.; Sakas, D.E.; Roussos, C. Protein S-100b serum levels in trauma-induced brain death. Neurology, 2003, 60, 947-51.
65. Ingebrigtsen, T.; Romner, B.; Marup-Jensen, S.; Dons, M.; Lundqvist, C.; Bellner, J.; Alling, C.; Borgesen, S.E. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj., 2000, 14, 1047-55.
66. Savola, O.; Hillbom, M. Early predictors of post-concussion symptoms in patients with mild head injury. Eur. J. Neurol., 2003, 10, 175-81.
67. Rothoerl, R.D.; Woertgen, C.; Holzschuh, M.; Metz, C.; Brawanski, A. S-100 serum levels after minor and major head injury. J. Trauma Inj. Infect. Crit. Care, 1998, 45, 765-7.
68. Stranjalis, G.; Korfias, S.; Papapetrou, C.; Kouyialis, A.T.; Boviatsis, E.J.; Psachoulia, C.; Sakas, D.E. Elevated serum S-100B protein as a predictor of failure to short-term return to work or activities after mild head injury. J. Neurotrauma, 2004, 21, 1070-5.
69. Townend, W.J.; Guy, M.J.; Pani, M.A.; Martin, B.; Yates, D.W. Head injury outcome prediction in the emergency department: a role for protein S-100B? J. Neurol. Neurosurg. Psychiatry, 2002, 73, 542-6.
70. Buttner, T.; Weyers, S.; Postert, T.; Sprengelmeyer, R.; Kuhn, W. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke, 1997, 28, 1961-5.
71. Wunderlich, M.T.; Ebert, A.D.; Kratz, T.; Goertler, M.; Jost, S.; Hermann, M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke, 1999, 30, 1190-5.
72. Wunderlich, M.T.; Wallesch, C.W.; Goertler, M. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. J. Neurol. Sci., 2004, 227, 49-53.
73. Abraha, H.D.; Butterworth, R.J.; Bath, P.M., Wassif, W.S.; Garthwaite, J.; Sherwood, R.A. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann. Clin. Biochem., 1997, 34, 546-50.
74. Thorngren-Jerneck, K.; Alling, C.; Herbst, A.; Amer-Wahlin, I.; Marsal, K. S100 protein in serum as a prognostic marker for cerebral injury in term newborn infants with hypoxic ischemic encephalopathy. Pediatr. Res., 2004, 55, 406-12.
75. Distefano, G.; Curreri, R.; Betta, P.; Isaja, M.T.; Romeo, M.G.; Amato, M. Serial protein S-100 serum levels in preterm babies with perinatal asphyxia and periventricular white matter lesions. Am. J. Perinatol., 2002, 19, 317-22.
76. Gazzolo, D.; Di Iorio, R.; Marinoni, E.; Masetti, P.; Serra, G.; Giovannini, L.; Michetti, F. S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit. Care Med., 2002, 30, 1356-60.
77. Gazzolo, D.; Vinesi, P.; Bartocci, M.; Geloso, M.C.; Bonacci, W.; Serra, G.; Haglid, K.G.; Michetti, F. Elevated S100 blood level as an early indicator of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J. Neurol. Sci., 1999, 170, 32-5.
78. Gazzolo, D.; Bruschettini, M.; Lituania, M.; Serra, G.; Bonacci, W.; Michetti, F. Increased urinary protein S-100B as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin. Chem., 2001, 47, 1836-8.
79. Gazzolo, D.; Marinoni, E.; di Iorio, R.; Lituania, M.; Bruschettini, P.L.; Michetti, F. Circulating S100beta protein is increased in intrauterine growth-retarded fetuses. Pediatr. Res., 2002, 51, 215-9.
80. Wiesmann, M.; Missler, U.; Hagenstrom, H.; Gottmann, D. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir., 1997, 139, 1155-60.
81. Schick, U.; Dohnert, J.; Meyer, J.J.; Vitzthum, H.E. Prognostic significance of SSEP, BAEP and serum S-100B monitoring after aneurysm surgery. Acta Neurol. Scand., 2003, 108, 161-9.
82. Stranjalis, G.; Korfias, S.; Psachoulia, C.; Kouyialis, A.; Sakas, D.E.; Mendelow, A.D. The prognostic value of serum S-100B protein in spontaneous subarachnoid haemorrhage. Acta Neurochir., 2007, 149, 231-7.
83. Stranjalis, G.; Korfias, S.; Psachoulia, C.; Boviatsis, E.; Kouyialis, A.; Protopappa, D.; Sakas, D.E. Serum S-100B as an indicator of early postoperative deterioration after meningioma surgery. Clin. Chem., 2005, 51, 202-7.
84. Vos, M.J.; Postma, T.J.; Martens, F.; Uitdehaag, B.M.; Blankenstein, M.A.; Vandertop, W.P.; Slotman, B.J.; Heimans, J.J. Serum levels of S-100B protein and neuron-specific enolase in glioma patients: a pilot study. Anticancer Res., 2004, 24, 2511-4.
85. Anderson, R.E.; Hansson, L.O.; Nilsson, O.; Dijlai-Merzoug, R.; Settergren, G. High serum S100B levels for trauma patients without head injuries. Neurosurgery, 2001, 48, 1255-8.
86. Korfias S, Stranjalis G, Psachoulia C, Vasiliadis C, Pitaridis M, Boviatsis E, Sakas DE. Slight and short-lasting increase of serum S-100B protein in extra-cranial trauma. Brain Inj., 2006, 28, 867-72.
87. Savola, O.; Pyhtinen, J.; Leino, T.K.; Siitonen, S.; Niemela, O.; Hillbom, M. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J. Trauma, 2004, 56, 1229-34.
88. Unden, J.; Bellner, J.; Eneroth, M.; Alling, C.; Ingebrigtsen, T.; Romner, B. Raised serum S100B levels after acute bone fractures without cerebral injury. J. Trauma, 2005, 58, 59-61.
89. Kleindienst, A.; Ross Bullock, M. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J. Neurotrauma, 2006, 23, 1185-200.
90. Pelsers, M.M.; Hanhoff, T.; Van der Voort, D.; Arts, B.; Peters, M.; Ponds, R.; Honig, A.; Rudzinski, W.; Spener, F.; de Kruijk, J.R.; Twijnstra, A.; Hermens, W.T.; Menheere, P.P.; Glatz, J.F. Brainand heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin. Chem., 2004, 50, 1568-75.
91. Bulut, M.; Koksal, O.; Dogan, S.; Bolca, N.; Ozguc, H.; Korfali, E.; Ilcol, Y.O.; Parklak, M. Tau protein as a serum marker of brain damage in mild traumatic brain injury: preliminary results. Adv. Ther., 2006, 23, 12-22.
92. Vos, P.E.; Lamers, K.J.; Hendriks, J.C.; Van Haaren, M.; Beems, T.; Zimmerman, C.; Van Geel, W.; De Reus, H.; Biert, J.; Verbeek, M.M. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology, 2004, 62, 1303-10.
93. Pelinka, L.E.; Kroepfl, A.; Leixnering, M.; Buchinger, W.; Raabe, A.; Redl, H. J. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. Neurotrauma, 2004, 21, 1553-61.
94. Berger, R.P.; Adelson, P.D.; Pierce, M.C.; Dulani, T.; Cassidy, L.D.; Kochanek, P.M. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J. Neurosurg., 2005, 103, 61-8.
95. Nylén, K.; Ost, M.; Csajbok, L.Z.; Nilsson, I.; Hall, C.; Blennow, K.; Nellgård, B.; Rosengren. L. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochir., (Wien), 2008, 150, 221-7.
96. da Rocha, A.B.; Zanoni, C.; de Freitas, G.R.; Andre, C.; Himelfarb, S.; Schneider, R.F.; Grivicich, I.; Borges, L.; Schwartsmann, G.; Kaufmann, M.; Regner, A. Serum Hsp70 as an early predictor of fatal outcome after severe traumatic brain injury in males. J. Neurotrauma, 2005, 22, 966-77.
97. Lumpkins. K.; Bochicchio, G.V.; Zagol, B.; Ulloa, K.; Simard, J.M.; Schaub, S.; Meyer, W.; Scalea, T. Plasma levels of the beta chemokine regulated upon activation, normal T cell expressed, and secreted (RANTES) correlate with severe brain injury. J. Trauma, 2008, 64, 358-61.
98. Sotgiu, S.; Zanda, B.; Marchetti, B.; Fois, M.L.; Arru, G.; Pes, G.M.; Salaris, F.S.; Arru, A.; Pirisi, A.; Rosati, G. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur. J. Neurol., 2006, 13, 505-13.
99. Vázquez, M.D.; Sánchez-Rodriguez, F.; Osuna, E.; Diaz, J.; Cox, D.E.; Pérez-Cárceles, M.D.; Martinez, P.; Luna, A.; Pounder, D.J. Creatine kinase BB and neuron-specific enolase in cerebrospinal fluid in the diagnosis of brain insult. Am. J. Forensic Med. Pathol., 1995, 16, 210-4.
100. Michetti, F.; Gazzolo, D. S100B protein in biological fluids: a tool for perinatal medicine. Clin. Chem., 2002, 48, 2097-104.
101. Pineda, J.A.; Lewis, S.B.; Valadka, A.B.; Papa, L.; Hannay, H.J.; Heaton, S.C.; Demery, J.A.; Liu, M.C.; Aikman, J.M.; Akle, V.; Brophy, G.M.; Tepas, J.J.; Wang, K.K.; Robertson, C.S.; Hayes, R.L. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma, 2007, 24, 354-66.
102. Stover, J.F.; Morganti-Kosmann, M.C.; Lenzlinger, P.M.; Stocker, R.; Kempski, O.S.; Kossmann, T. Glutamate and taurine are increased in ventricular cerebrospinal fluid of severely brain-injured patients. J. Neurotrauma, 1999, 16, 135-42.
103. Pilitsis, J.G.; Coplin, W.M.; O'Regan, M.H.; Wellwood, J.M.; Diaz. F.G.; Fairfax, M.R.; Michael, D.B.; Phillis, J.W. Free fatty acids in cerebrospinal fluids from patients with traumatic brain injury. Neurosci. Lett., 2003, 349, 136-8.
104. Satchell, M.A.; Lai, Y.; Kochanek, P.M.; Wisniewski, S.R.; Fink, E.L.; Siedberg, N.A.; Berger, R.P.; DeKosky, S.T.; Adelson, P.D.; Clark, R.S. Cytochrome c, a biomarker of apoptosis, is increased in cerebrospinal fluid from infants with inflicted brain injury from child abuse. J. Cereb. Blood Flow Metab., 2005, 25, 919-27.
105. Lai, Y.; Stange, C.; Wisniewski, S.R.; Adelson, P.D.; Janesko-Feldman, K.L.; Brown, D.S.; Kochanek, P.M.; Clark, R.S. Mitochondrial heat shock protein 60 is increased in cerebrospinal fluid following pediatric traumatic brain injury. Dev. Neurosci., 2006, 28, 336-41.
106. Darwish, R.S.; Amiridze, N.; Aarabi, B. Nitrotyrosine as an oxidative stress marker: evidence for involvement in neurologic outcome in human traumatic brain injury. J. Trauma, 2007, 63, 439-42.
107. Osterlundh, G.; Kjellmer, I.; Lannering, B.; Rosengren, L.; Nilsson, U.A.; Márky, I. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children. Pediatr. Blood Cancer, 2008, 50, 793-8.